alexa Is the 5-iodo-2-aminoindan (5-IAI) the New MDMA? | OMICS International | Abstract
ISSN: 2155-6105

Journal of Addiction Research & Therapy
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Is the 5-iodo-2-aminoindan (5-IAI) the New MDMA?

Coppola M1* and Mondola R2

1Department of Addiction, ASL CN2, Viale Coppino 46, 12051, Alba (CN), Italy

2Department of Mental Health, ASL CN1, Via Torino 70/B, 12037, Saluzzo (CN), Italy

*Corresponding Author:
Coppola M
Department of Addiction
ASL CN2, Viale Coppino 46
12051, Alba (CN), Italy
Tel: +390173316210
Fax: +390173420344
E-mail: [email protected]

Received August 28, 2012; Accepted September 22, 2012; Published September 30, 2012

Citation: Coppola M, Mondola R (2012) Is the 5-iodo-2-aminoindan (5-IAI) the New MDMA? J Addict Res Ther 3:134. doi:10.4172/2155-6105.1000134

Copyright: © 2012 Coppola M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Between 1997 and 2011, more than 200 new substances have been officially notified in European Union via the Early Warning System with the largest number of compounds ever reported in a single year in 2011 (49 substances). In 2010, an internet snapshot anticipated the presence of 5-iodo 2-aminoindan (5-IAI) within the recreational drug market. In 2011, this compound, a psychoactive analog of p-iodoamphetamine, was identified in United Kingdom. The aim of this paper is to summarize the clinical, pharmacological and toxicological information currently available about this new potential recreational drug.

Keywords

Top